{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:14:41Z","timestamp":1787228081273,"version":"build-2736575974"},"reference-count":41,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":235,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chuzhou University Scientific Research Fund","award":["2020qd50"],"award-info":[{"award-number":["2020qd50"]}]},{"name":"Chuzhou University Scientific Research Fund","award":["2022XJYB10"],"award-info":[{"award-number":["2022XJYB10"]}]},{"DOI":"10.13039\/501100017668","name":"Key Research and Development Program of Anhui Province","doi-asserted-by":"publisher","award":["202104b11020010"],"award-info":[{"award-number":["202104b11020010"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017668","name":"Key Research and Development Program of Anhui Province","doi-asserted-by":"publisher","award":["S202110377140"],"award-info":[{"award-number":["S202110377140"]}],"id":[{"id":"10.13039\/501100017668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acute myelogenous leukemia (AML) remains a serious fatal disease for the patients and effective treatment strategies are urgently needed. Based on the characteristics of the AML, we developed the CD44 and bone targeting liposomes delivery system decorated with the redox-cleavable polymer. First, ALN-HA was obtained by amination between alendronate (ALN) and hyaluronic acid (HA), and cholesterol (Chol) was coupled by a disulfide linker (-SS-) with biological reducibility to obtain the goal polymer, ALN-HA-SS-Chol, decorated the liposomes loaded with the Cytarabine (AraC). ALN-HA-SS-AraC-Lip exhibited a spherical morphology with the diameter of 117.5\u2009nm and expanded at the environment of 10\u2009mM dithiothreitol. Besides, compared with other groups, ALN-HA-SS-AraC-Lip showed benign hydroxyapatite affinity in vitro and bone targeting in C57\/BL6 mice, also, ALN-HA-SS-AraC-Lip exhibited encouraging antitumor which significantly reduced the white blood cell amount in bone marrow and blood smear caused by AML model, besides, the dual targeting liposomes also prolong the survival time of mice. In conclusion, the bone and CD44 dual targeting liposomes with redox sensitivity could target to the leukemia stem cells regions and then uptake by the tumor cells, which would be a valuable target for the treatment of the AML.<\/jats:p>","DOI":"10.1093\/rb\/rbac058","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T13:54:51Z","timestamp":1661349291000},"source":"Crossref","is-referenced-by-count":24,"title":["Cytarabine delivered by CD44 and bone targeting redox-sensitive liposomes for treatment of acute myelogenous leukemia"],"prefix":"10.1093","volume":"9","author":[{"given":"Hao","family":"Wu","sequence":"first","affiliation":[{"name":"College of Materials & Chemical Engineering, Chuzhou University , Chuzhou 239000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Beijing Shunyi Hospital , Shunyi District, Beijing 101300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Shunyi Hospital , Shunyi District, Beijing 101300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosong","family":"Hu","sequence":"additional","affiliation":[{"name":"College of Materials & Chemical Engineering, Chuzhou University , Chuzhou 239000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xia","sequence":"additional","affiliation":[{"name":"College of Materials & Chemical Engineering, Chuzhou University , Chuzhou 239000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Bao","sequence":"additional","affiliation":[{"name":"College of Materials & Chemical Engineering, Chuzhou University , Chuzhou 239000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Materials & Chemical Engineering, Chuzhou University , Chuzhou 239000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Shunyi Hospital , Shunyi District, Beijing 101300, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"2022091316455166600_rbac058-B1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.blre.2017.01.003","article-title":"Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia","volume":"31","author":"Percival","year":"2017","journal-title":"Blood Rev"},{"key":"2022091316455166600_rbac058-B2","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1056\/NEJMe1012071","article-title":"Genetics, epigenetics, and leukemia","volume":"363","author":"Shannon","year":"2010","journal-title":"N Engl J Med"},{"key":"2022091316455166600_rbac058-B3","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/ajh.24207","article-title":"Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the \u201c3\u2009+\u20097\u201d induction regimen for acute myeloid leukemia","volume":"90","author":"Ofran","year":"2015","journal-title":"Am J Hematol"},{"key":"2022091316455166600_rbac058-B4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1200\/JCO.1992.10.6.948","article-title":"Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia","volume":"10","author":"Rubin","year":"1992","journal-title":"J Clin Oncol"},{"key":"2022091316455166600_rbac058-B5","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/anie.200805133","article-title":"Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer\u2013alendronate\u2013taxane conjugate","volume":"48","author":"Miller","year":"2009","journal-title":"Angew Chem Int Ed Engl"},{"key":"2022091316455166600_rbac058-B6","doi-asserted-by":"crossref","first-page":"125146","DOI":"10.1016\/j.matchemphys.2021.125146","article-title":"Fabrication of bone-targeting hyaluronic acid coupled alendronate-bioactive glass for osteosarcoma therapy","volume":"273","author":"Mehnath","year":"2021","journal-title":"Mater Chem Phys"},{"key":"2022091316455166600_rbac058-B7","doi-asserted-by":"crossref","first-page":"18387","DOI":"10.1039\/C8NR03899F","article-title":"Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy","volume":"10","author":"Zhu","year":"2018","journal-title":"Nanoscale"},{"key":"2022091316455166600_rbac058-B8","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.nano.2018.07.011","article-title":"Bone-targeting liposome formulation of salvianic acid a accelerates the healing of delayed fracture union in mice","volume":"14","author":"Liu","year":"2018","journal-title":"Nanomedicine"},{"key":"2022091316455166600_rbac058-B9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","article-title":"Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation","volume":"229","author":"Ravar","year":"2016","journal-title":"J Control Release"},{"key":"2022091316455166600_rbac058-B10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2020.02.004","article-title":"CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice","volume":"320","author":"Zhong","year":"2020","journal-title":"J Control Release"},{"key":"2022091316455166600_rbac058-B11","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.biomaterials.2013.01.077","article-title":"Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors","volume":"34","author":"Ganesh","year":"2013","journal-title":"Biomaterials"},{"key":"2022091316455166600_rbac058-B12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drup.2008.04.002","article-title":"Hyaluronan, CD44 and emmprin: partners in cancer cell chemoresistance","volume":"11","author":"Toole","year":"2008","journal-title":"Drug Resist Updat"},{"key":"2022091316455166600_rbac058-B13","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1080\/10717544.2017.1384864","article-title":"Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles","volume":"24","author":"Zhong","year":"2017","journal-title":"Drug Deliv"},{"key":"2022091316455166600_rbac058-B14","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1021\/acs.molpharmaceut.8b00266","article-title":"In vivo evaluation of reduction-responsive alendronate-hyaluronan-curcumin polymer-drug conjugates for targeted therapy of bone metastatic breast cancer","volume":"15","author":"Wang","year":"2018","journal-title":"Mol Pharm"},{"key":"2022091316455166600_rbac058-B15","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.addr.2008.06.001","article-title":"Pro-oxidant shift in glutathione redox state during aging","volume":"60","author":"Rebrin","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"2022091316455166600_rbac058-B16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/10428190009060329","article-title":"The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages","volume":"38","author":"Alemany","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"2022091316455166600_rbac058-B17","doi-asserted-by":"crossref","first-page":"11408","DOI":"10.1021\/ja0704683","article-title":"Dramatic influence of the orientation of linker between hydrophilic and hydrophobic lipid moiety in liposomal gene delivery","volume":"129","author":"Rajesh","year":"2007","journal-title":"J Am Chem Soc"},{"key":"2022091316455166600_rbac058-B18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijbiomac.2020.10.088","article-title":"Preparation, characterization and in vitro antitumor activity evaluation of hyaluronic acid-alendronate-methotrexate nanoparticles","volume":"166","author":"Gao","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"2022091316455166600_rbac058-B19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2015.01.020","article-title":"Preparation of an injectable depot system for long-term delivery of alendronate and evaluation of its anti-osteoporotic effect in an ovariectomized rat model","volume":"480","author":"Bae","year":"2015","journal-title":"Int J Pharm"},{"key":"2022091316455166600_rbac058-B20","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.2147\/IJN.S113469","article-title":"GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy","volume":"11","author":"Hu","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"2022091316455166600_rbac058-B21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2015.02.026","article-title":"Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation","volume":"203","author":"Zhang","year":"2015","journal-title":"J Control Release"},{"key":"2022091316455166600_rbac058-B22","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1039\/C8BM00486B","article-title":"Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer","volume":"6","author":"Sun","year":"2018","journal-title":"Biomater Sci"},{"key":"2022091316455166600_rbac058-B23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/mp800218q","article-title":"Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals","volume":"6","author":"Du","year":"2009","journal-title":"Mol Pharm"},{"key":"2022091316455166600_rbac058-B24","doi-asserted-by":"crossref","first-page":"rbac007","DOI":"10.1093\/rb\/rbac007","article-title":"Orthodontics by polymeric \u2018clear\u2019 aligners molded on 3D-printed personalized dental models","volume":"9","author":"Yu","year":"2022","journal-title":"Regen Biomater"},{"key":"2022091316455166600_rbac058-B25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2017.10.053","article-title":"Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis","volume":"154","author":"Yamashita","year":"2018","journal-title":"Biomaterials"},{"key":"2022091316455166600_rbac058-B26","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.ijbiomac.2020.08.068","article-title":"Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors","volume":"164","author":"Wu","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"2022091316455166600_rbac058-B27","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.2147\/IJN.S119839","article-title":"Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded pluronic P105\/D-\u03b1-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment","volume":"11","author":"Wu","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"2022091316455166600_rbac058-B28","doi-asserted-by":"crossref","first-page":"rbab033","DOI":"10.1093\/rb\/rbab033","article-title":"ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis","volume":"8","author":"Tang","year":"2021","journal-title":"Regen Biomater"},{"key":"2022091316455166600_rbac058-B29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3816\/CBC.2010.n.059","article-title":"The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial","volume":"10","author":"Jensen","year":"2010","journal-title":"Clin Breast Cancer"},{"key":"2022091316455166600_rbac058-B30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biomaterials.2018.03.013","article-title":"Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy","volume":"167","author":"Deng","year":"2018","journal-title":"Biomaterials"},{"key":"2022091316455166600_rbac058-B31","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1021\/mp4001266","article-title":"Multistep targeted nano drug delivery system aiming at leukemic stem cells and minimal residual disease","volume":"10","author":"Shi","year":"2013","journal-title":"Mol Pharm"},{"key":"2022091316455166600_rbac058-B32","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1166\/jbn.2017.2464","article-title":"An injectable thermogel containing levonorgestrel for long-acting contraception and fertility control of animals","volume":"13","author":"Chen","year":"2017","journal-title":"J Biomed Nanotechnol"},{"key":"2022091316455166600_rbac058-B33","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1021\/acsami.8b18820","article-title":"Engineering of bone- and CD44-dual-targeting redox-sensitive liposomes for the treatment of orthotopic osteosarcoma","volume":"11","author":"Feng","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"2022091316455166600_rbac058-B34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2021.05.033","article-title":"A dual macrophage polarizer conjugate for synergistic melanoma therapy","volume":"335","author":"Sallam","year":"2021","journal-title":"J Control Release"},{"key":"2022091316455166600_rbac058-B35","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/nbt1350","article-title":"Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region","volume":"25","author":"Ishikawa","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2022091316455166600_rbac058-B36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2017.06.027","article-title":"Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models","volume":"261","author":"Chi","year":"2017","journal-title":"J Control Release"},{"key":"2022091316455166600_rbac058-B37","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1016\/j.biomaterials.2013.01.052","article-title":"Poly (ethylene glycol)\u2013paclitaxel\u2013alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases","volume":"34","author":"Miller","year":"2013","journal-title":"Biomaterials"},{"key":"2022091316455166600_rbac058-B38","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.7150\/thno.42260","article-title":"Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy","volume":"11","author":"Zou","year":"2021","journal-title":"Theranostics"},{"key":"2022091316455166600_rbac058-B39","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.3390\/ijms19082310","article-title":"Hyaluronic acid-decorated chitosan nanoparticles for CD44-targeted delivery of everolimus","volume":"19","author":"Chiesa","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2022091316455166600_rbac058-B40","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1182\/blood-2007-01-068346","article-title":"AML1 mutations induced MDS and MDS\/AML in a mouse BMT model","volume":"111","author":"Watanabe-Okochi","year":"2008","journal-title":"Blood"},{"key":"2022091316455166600_rbac058-B41","first-page":"21","article-title":"Distribution of fusion transcripts and its clinical impact in patients with acute myeloid leukemia in Sudan","volume":"15","author":"Muddathir","year":"2021","journal-title":"Int J Health Sci (Qassim)"}],"container-title":["Regenerative Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rb\/advance-article-pdf\/doi\/10.1093\/rb\/rbac058\/45509243\/rbac058.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rb\/article-pdf\/doi\/10.1093\/rb\/rbac058\/45813350\/rbac058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rb\/article-pdf\/doi\/10.1093\/rb\/rbac058\/45813350\/rbac058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T16:47:39Z","timestamp":1663087659000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rb\/article\/doi\/10.1093\/rb\/rbac058\/6674520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1093\/rb\/rbac058","relation":{},"ISSN":["2056-3426"],"issn-type":[{"value":"2056-3426","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2022,1,1]]},"article-number":"rbac058"}}